SCWorx (WORX) Non-Current Debt (2018 - 2024)

SCWorx's (WORX) quarterly Non-Current Debt came in at $41949.0 in Q3 2024, down 58.01% year-on-year from $99902.0 in Q4 2023, and down 25.74% quarter-over-quarter from $56492.0 in Q2 2024.

SCWorx (WORX) Non-Current Debt (2018 - 2024) Analysis & Trends

SCWorx has disclosed Non-Current Debt across 6 years of filings, most recently posting $41949.0 for Q3 2024.

  • Non-Current Debt for Q3 2024 came in at $41949.0, down 58.01% year-over-year; the trailing twelve-month figure through Sep 2024 was $41949.0 (down 58.01% YoY), and the FY2023 annual result was $90359.0, down 38.84% from the prior year.
  • Non-Current Debt came in at $41949.0 for Q3 2024 at SCWorx, down from $56492.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $433567.0 in Q1 2021 to a low of $41949.0 in Q3 2024.
  • The 5-year median for Non-Current Debt is $293972.0 (2020), against an average of $237524.2.
  • Across the five-year window, Non-Current Debt soared 47.49% in 2021 and sank 65.92% in 2022, its largest moves.
  • SCWorx's Non-Current Debt stood at $293972.0 in 2020, then soared by 47.49% to $433567.0 in 2021, then tumbled by 65.92% to $147749.0 in 2022, then plunged by 38.84% to $90359.0 in 2023, then plunged by 53.58% to $41949.0 in 2024.
  • The last three Non-Current Debt figures came in at $41949.0 (Q3 2024), $56492.0 (Q2 2024), and $90359.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 2.44 Bn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 942.66 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn -
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 1.46 Bn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn -
10 SCWorx - - 374,109.00 -

Historic Data

Download Data
DateValue
Sep 30, 2024 41,949.00
Sep 30, 2024 41,949.00
Jun 30, 2024 56,492.00
Jun 30, 2024 56,492.00
Dec 31, 2023 90,359.00
Dec 31, 2023 90,359.00
Sep 30, 2023 99,902.00
Sep 30, 2023 99,902.00
Jun 30, 2023 114,298.00
Jun 30, 2023 114,298.00
Mar 31, 2023 128,659.00
Mar 31, 2023 128,659.00
Dec 31, 2022 147,749.00
Dec 31, 2022 147,749.00
Sep 30, 2022 154,376.00
Sep 30, 2022 154,376.00
Jun 30, 2022 293,972.00
Jun 30, 2022 293,972.00
Mar 31, 2022 293,972.00
Mar 31, 2022 293,972.00